Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.34 USD | +14.27% | +26.90% | +13.63% |
Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Bullish |
Resistance | 24.73 | 26.47 | 25.87 |
Spread/Res. | -1.58% | -8.05% | -5.91% |
Spread/Supp. | +28.99% | +75.74% | +26.44% |
Support | 18.87 | 13.85 | 19.25 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ANAB Stock
- Charts AnaptysBio, Inc.